FDA notifications.  Pediatric dosing recommendations revised.
D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000008:administration & dosage*
D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine